MediPharm Labs Corp. (OTCMKTS:MEDIF) Sees Significant Drop in Short Interest

MediPharm Labs Corp. (OTCMKTS:MEDIF) was the recipient of a large drop in short interest in the month of February. As of February 13th, there was short interest totaling 71,786 shares, a drop of 56.9% from the January 29th total of 166,605 shares. Based on an average daily volume of 227,635 shares, the short-interest ratio is presently 0.3 days. Based on an average daily volume of 227,635 shares, the short-interest ratio is presently 0.3 days.

MediPharm Labs Trading Down 0.6%

Shares of MEDIF stock traded down $0.00 during trading hours on Friday, hitting $0.05. The stock had a trading volume of 71,370 shares, compared to its average volume of 72,950. MediPharm Labs has a one year low of $0.04 and a one year high of $0.09. The stock’s 50-day moving average price is $0.05 and its two-hundred day moving average price is $0.05.

About MediPharm Labs

MediPharm Labs Corporation is a Canada-based company focused on the extraction, formulation and manufacturing of pharmaceutical-grade cannabis products. Through proprietary processes and a GMP-compliant facility in Mississauga, Ontario, the company produces high-purity distillates, isolates and advanced formulations tailored to both medical and adult-use markets.

The company’s core offerings include THC and CBD distillates, crystalline isolates, softgel capsules, oral thin films and sterile injectable products.